Jump to main content
Jump to site search

Issue 6, 2013
Previous Article Next Article

Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer

Author affiliations

Abstract

The objective of this study was to evaluate the biocompatibility of zirconium phosphate (ZrP) nanoplatelets (NPs), and their use in drug delivery. ZrP and doxorubicin-intercalated ZrP (DOX:ZrP) NPs were characterized by using X-Ray Powder Diffraction (XRPD), Thermogravimetric Analysis (TGA), Transmission Electron Micrography (TEM), Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM). Biocompatibility of ZrP NPs was evaluated in human embryonic kidney (HEK-293), breast cancer (MCF-7), metastatic breast cancer (MDA-MB-231), ovarian cancer (OVCAR-3), resistant cancer (NCI-RES/ADR) cells and mouse macrophage (RAW 264.7) cell lines. Hemocompatibility of ZrP NPs was evaluated with human red blood cells. Simulated body fluid (SBF) of pH 7.4 was used to determine the in vitro release of doxorubicin from DOX:ZrP NPs. Cellular uptake and in vitro cytotoxicity studies of DOX:ZrP NPs were determined in MDA-MB-231. The ZrP nanomaterial can be prepared in the 100–200 nm size range with a platelet-like shape. The ZrP NPs themselves are biocompatible, hemocompatible and showed no toxicity to the macrophage cells. ZrP NPs can intercalate high loads (35% w/w) of doxorubicin between their layers. The release of DOX was sustained for about 2 weeks. DOX:ZrP NPs showed higher cellular uptake and increased cytotoxicity than free DOX in MDA-MB-231 cells. ZrP NPs are highly biocompatible, can intercalate large amounts of drugs and sustain the release of drugs. ZrP NPs improved the cellular uptake and cytotoxicity of DOX to MDA-MB-231 cells. ZrP NPs are promising nanocarriers for drug delivery in cancer therapy.

Graphical abstract: Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 Dec 2012, accepted on 14 Jan 2013 and first published on 18 Jan 2013


Article type: Paper
DOI: 10.1039/C3NR34242E
Citation: Nanoscale, 2013,5, 2328-2336
  •   Request permissions

    Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer

    V. Saxena, A. Diaz, A. Clearfield, J. D. Batteas and M. D. Hussain, Nanoscale, 2013, 5, 2328
    DOI: 10.1039/C3NR34242E

Search articles by author

Spotlight

Advertisements